Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Dacek MM"'
Autor:
Kurtz K; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA., Eibler L; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA., Carter LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Veach DR; Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA., Lovibond S; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Reynaud E; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Qureshy S; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., McDevitt MR; Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA., Bourne C; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY 10065, USA., Monette S; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and The Rockefeller University, New York, NY 10065, USA., Punzalan B; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Khayat S; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA., Verma S; Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA., Kesner AL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Schöder H; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA., Gajecki L; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cheal SM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA., Larson SM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA., Krebs S; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA.
Publikováno v:
Theranostics [Theranostics] 2023 Oct 08; Vol. 13 (15), pp. 5469-5482. Date of Electronic Publication: 2023 Oct 08 (Print Publication: 2023).
Autor:
Bourne CM; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wallisch P; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Dacek MM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Gardner TJ; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Pierre S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Vogt K; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York., Corless BC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Bah MA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Romero-Pichardo JE; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Charles A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Kurtz KG; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Tan DS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York.; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Scheinberg DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Sep 01; Vol. 11 (9), pp. 1253-1265.
Autor:
Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY., Kurtz KG; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY., Wallisch P; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY., Pierre SA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Tri-institutunal MD-PhD Program, Weill Cornell Medicine, New York, NY., Khayat S; Pharmacology Program, Weill Cornell Medicine, New York, NY.; Immunology Program, Sloan Kettering Institute, New York, NY., Bourne CM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine, New York, NY., Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Vogt KC; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, The Rockefeller University, New York, NY., Aquino N; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY., Younes A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood [Blood] 2023 Apr 20; Vol. 141 (16), pp. 2003-2015.
Autor:
Klatt MG; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Dao T; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Yang Z; Eureka Therapeutics, Emeryville, CA., Liu J; Eureka Therapeutics, Emeryville, CA., Mun SS; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Luo H; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Bourne C; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Immunology and Microbial Pathogenesis Program and., Peraro L; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Aretz ZEH; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Physiology, Biophysics and Systems Biology Program, Weill Cornell Medicine, New York, NY., Korontsvit T; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Lau M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY; and., Kharas MG; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Liu C; Eureka Therapeutics, Emeryville, CA., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY.
Publikováno v:
Blood [Blood] 2022 Aug 25; Vol. 140 (8), pp. 861-874.
Autor:
Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee JP; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bourne CM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wijewarnasuriya D; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; BCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kinarivala N; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kurtz KG; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Corless BC; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chang AY; BCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mo G; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nguyen KM; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brentjens RJ; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tan DS; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org.; Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2022 Feb; Vol. 18 (2), pp. 216-225. Date of Electronic Publication: 2021 Dec 30.
Autor:
Peraro L; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Bourne CM; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA., Dacek MM; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA., Akalin E; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Smith EL; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Scheinberg DA; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: scheinbd@mskcc.org.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Dec 01; Vol. 29 (12), pp. 3398-3409. Date of Electronic Publication: 2021 Jul 02.
Autor:
Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Department of Pharmacology, Weill Cornell Medical College, New York, New York 10065, United States., Veach DR; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Department of Radiology, Weill Cornell Medical College, New York, New York 10065, United States., Cheal SM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Carter LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., McDevitt MR; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Department of Radiology, Weill Cornell Medical College, New York, New York 10065, United States., Punzalan B; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Burnes Vargas D; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Kubik TZ; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Monette S; Tri-Institutional Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and The Rockefeller University, New York, New York 10065, United States., Santich BH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Yang G; Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Ouerfelli O; Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Kesner AL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Department of Pharmacology, Weill Cornell Medical College, New York, New York 10065, United States., Larson SM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Department of Radiology, Weill Cornell Medical College, New York, New York 10065, United States., Krebs S; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Department of Radiology, Weill Cornell Medical College, New York, New York 10065, United States.
Publikováno v:
Bioconjugate chemistry [Bioconjug Chem] 2021 Apr 21; Vol. 32 (4), pp. 649-654. Date of Electronic Publication: 2021 Apr 05.
Autor:
Krebs S; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, United States.; Pharmacology Department, Weill Cornell Medicine, New York, NY, United States., Carter LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, United States.; Pharmacology Department, Weill Cornell Medicine, New York, NY, United States., Larson SM; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2020 Sep 11; Vol. 10, pp. 577773. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Autor:
Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA., Bourne CM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA.; Immunology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Kurtz K; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Malviya M; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA., Peraro L; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA., Silberman PC; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Vogt KC; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Unti MJ; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Brentjens R; Department of Medicine, Memorial Hospital, New York, NY 10065, USA., Scheinberg D; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY 10065, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.; Department of Medicine, Memorial Hospital, New York, NY 10065, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Aug 05; Vol. 12 (8). Date of Electronic Publication: 2020 Aug 05.
Autor:
Oh CY; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Klatt MG; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Bourne C; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Dao T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Dacek MM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Brea EJ; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Mun SS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Chang AY; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Korontsvit T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Scheinberg DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. scheinbd@mskcc.org.; Weill Cornell Medicine, New York, New York.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Dec; Vol. 7 (12), pp. 1984-1997. Date of Electronic Publication: 2019 Sep 20.